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Endoluminal repair of abdominal aortic aneurysms (AAA) requires the aneurysm to have a proximal neck of at least 
1.5 cm between the renal arteries and the aneurysm. Therefore, there may be advantages in performing endoluminal repair 
in the early stages of aneurysm development. However, the results of endoluminal repair performed in patients with small 
aneurysms with favourable morphology are not known. The aim of this study was to determine whether a randomised 
trial of endoluminal repair vs. no treatment for small aneurysms would be justified by using a concurrent comparison of 
endoluminal repair vs. no treatment for AAA 5 cm or less in diameter in patients presenting to the same centre during 
a 4-year period. 
Methods: Data on 117 patients presenting with AAA 5 cm or less in diameter were entered into a registry. The decision 
to perform endoluminal repair vs. no treatment was based on the patient's preference following surgical consultation and 
investigation by computed tomography. This study reports the mortality, morbidity and survival of patients presenting 
between June 1992 and August 1996. During this time 43 patients had endoluminal repair and 67 patients had no 
treatment for small AAA. Seven patients were unfit for any intervention. Despite patient selection for different management 
in each group, close analysis revealed that the groups were similar with regard to co-morbidities and risk factors, as well 
as age, sex, and size of aneurysm. Follow-up was by progress CT scanning and ranged from 1 to 51 months (mean 18 
months (NT) and 22 months (ER)). 
Results: Endoluminal repair failed in six of 43 patients (14%) and resulted in 11 (25%) local vascular complications. 
There were two perioperative deaths and one late death in this group. Twenty-one of 67 AAA (31%) patients in the no 
treatment group enlarged beyond 5 cm in diameter during the study period. There was one death from aneurysm rupture 
and one death from myocardial infarction in this group. 
Conclusions: The patients in the endoluminal repair group have gained an asset in having their aneurysms repaired at 
a cost of early morbidity following operation. These results suggest hat a randomised trial of endoluminal repair vs. no 
treatment will become justified in the subset of patients with small AAA 5 cm or less, if the incidence of complications 
can be reduced by further improvements in endoluminal technology. 
Introduction 
Only half of the patients with abdominal aortic an- 
eurysms (AAA) presenting for treatment are suitable 
for endoluminal repair with the current range of de- 
vices as shown in our study 1 and those of Chuter et 
al. 2 and Beebe et al. 3 The major cause for this has been 
a proximal neck of inadequate length. Endoluminal 
repair of AAA requires the aneurysm to have a prox- 
imal neck of at least 1.5 cm in length. It is also known 
that the pathological process which weakens the aortic 
wall in aneurysmal disease xtends progressively from 
the aneurysm itself into the proximal neck. Therefore, 
Presented at the 10th annual meeting of the European Society for 
Vascular Surgery, Venice, Italy (12-15 September 1996). * Please 
address all correspondence to: Professor James May, Department of 
Surgery, University of Sydney, NSW 2006, Australia. 
there may be advantages in performing endoluminal 
repair in the early stages of aneurysm development. 
However, the results of endoluminal repair performed 
in patients with small aneurysms with favourable 
morphology are not known. To determine whether a 
randomised trial of endoluminal repair vs. no treat- 
ment for small aneurysms would be justified, we 
compared the results of endoluminal repair vs. no 
treatment for abdominal aortic aneurysms 5 cm or less 
in diameter in patients presenting to the same centre 
during a 4 year period. 
Methods 
Data on 117 patients presenting with AAA 5 cm or 
less in diameter between May 1992 and August 1996 
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Table 1. Characteristics of patients in each group. 
No Endoluminal 
treatment repair 
Number of patients 67 43 
Mean age (years) 71.4 69.6 
Sex M/F 58:9 40:3 
Maximum diameter AAA (mean in cm) 4.08 4.41 
Ischaemic heart disease (%) 34 (51) 19 (45) 
Hypertension (%) 19 (28) 8 (19) 
Pulmonary disease (%) 9 (14) 4 (10) 
Diabetes mellitus (%) 5 (8) 4 (10) 
Chronic renal failure (%) 0 (0) 1 (2) 
Transient ischaemic attack (%) 1 (1) 2 (5) 
were entered into a register. All patients underwent 
clinical examination and were investigated by contrast 
enhanced computed tomography (CT). On the basis of 
this and additional information including cardiology 
consultation and investigation, seven patients were 
considered unfit for any intervention for their AAA 
and were excluded from the study. Sixteen patients 
were considered unsuitable for endoluminal AAA re- 
pair on the basis of their CT studies and were placed 
in the no treatment group. Following surgical con- 
sultation, the remaining patients were offered the 
choice of endoluminal repair or no treatment. In- 
formation given to the patient included the dimensions 
of the AAA in the particular patient; the average 
growth rate in AAA of 0.4 cm in diameter per year; 
and the nationally accepted iameter of 5 cm at which 
operation for AAA is recommended. Patients were 
also made aware that the long-term outcome following 
endoluminal repair of AAA is not known. During the 
study period 43 patients had endoluminal repair and 
67 patients had no treatment for small AAA. 
Despite patient selection for different management 
in each group, close analysis revealed that the groups 
were similar with regard to co-morbidities and risk 
factors, as well as age, sex and size of aneurysm (Table 
1). Although it is not the policy of the Department of
Vascular Surgery to offer open repair to patients with 
AAA less than 5 cm in diameter, examination of the 
records revealed five patients in this category who 
had open AAA repair during the period of the study. 
Endoluminal repair group 
Endoluminal aneurysm repair was performed in the 
operating room in all 43 patients. Patient characteristics 
and co-morbidities are listed in Table 1. Patients were 
prepared and draped for open repair in the event of 
failed endoluminal repair. The endografts used were 
the modified Parodi (n =2), the EVT (Endovascular 
Technologies) (n--8), White-Yu (n =27), the Mintec 
Stentor (n=5) and the Chuter (n=l). The graft con- 
figuration was a tubular in 26, aortoiliac in five and 
bifurcated in 12. Surgical exposure of the access artery 
was used in all cases. This was the common femoral 
in 39 and the common iliac via a dacron conduit in 
four. The size of the introducing sheath was 24F in all 
patients with the exception of those receiving Stentor 
and Chuter devices. The surgical technique used for 
each type of endograft has previously been described 
in detail. ~-s Fluoroscopic monitoring and an on-table 
post-procedure aortogram were performed in all cases. 
Follow-up consisted of clinical examination and con- 
trast enhanced CT of the aorta before discharge and 
at 6 monthly intervals thereafter. The duration of 
follow-up ranged from 6 to 51 months with a mean 
of 22 months. 
No treatment group 
Sixty-seven patients with AAA 5 cm or less in diameter 
were managed conservatively with correction of risk 
factors, hypertension, cardiovascular disease and lip- 
ids. Patient characteristics and co-morbidities were 
similar to the endoluminal group (Table 1). Patients 
in this group were followed up at intervals of 6 or 12 
months by clinical examination and contrast enhanced 
CT. The duration of follow-up ranged from 1 to 51 
months with a mean of 18 months. Patients with 
AAA growing in excess of 5cm diameter were offered 
intervention. 
Results 
Endoluminal repair group 
Endoluminal repair failed in six of 43 patients (14%), 
requiring conversion to open repair. Four of these 
occurred at the original operation and two were sec- 
ondary conversions. Two of the primary conversions 
were due to access problems early in our experience 
while the remaining two were due to inability to 
deploy a bifurcated graft. The two secondary con- 
versions resulted from inadvertent deployment of the 
endograft over the orifices of the renal arteries. Anuria 
was total in one of these patients and conversion to 
open repair was undertaken within 7h of the en- 
doluminal repair following a confirmatory plain X-ray 
of the abdomen which demonstrated the upper end 
of the endograft to be opposite the twelfth thoracic 
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Table 2. Local vascular complications: endoluminal repair group. 
Early Late 
Femoral artery damage 1 
Thrombosis 
one limb of bifurcated endograft 1 
native iliac artery 2 
Renal arteries covered 2 
Endoleak 
late - one corrected endoluminally 2 
Wound complications 
haematoma 1 
lymphocoele 1 
infection 1 
Total 8 3 
vertebra. In the second patient anuria was incomplete, 
resulting in delay in diagnosis and conversion to open 
repair being undertaken 24 h following endoluminal 
repair. Both patients required dialysis. 
Local vascular complications occurred in 11 patients 
(Table 2). Since this study forms a subgroup of our 
total experience, many of these complications have 
been documented previously. 1'9 One patient with fem- 
oral artery damage required vein patch repair. Throm- 
bosis occurred in the contralateral common iliac artery 
to the one being used for access in two patients. 
Patency was re-established endoluminally with the 
aid of a stent in one patient while the other required 
a femorofemoral cross-over graft to revascularise the 
contralateral limb. Thrombosis also occurred in one 
limb of a bifurcated Stentor endograft 6 months after 
operation. No endoleaks 1°were observed in the peri- 
operative period but two were seen in a late follow- 
up. One occurred 18 months after implantation of an 
EVT tube endograft. This followed rotation of the 
inferior attachment device which was observed on 
plain abdominal X-ray during the preceding 6 
months. 11 The second endoleak occurred 2 years fol- 
lowing implantation of a tubular White-Yu endograft. 
The endoleak occurred at the junction of the two 
component parts of the endograft using the "trombone 
technique". 12This was able to be corrected endo- 
luminally by insertion of a third White-Yu endograft 
to exclude the aneurysmal sac. 
Systemic/remote complications occurred in 10 
patients (Table 3). Renal insufficiency was the most 
worrying of these complications, occurring in four 
patients. Two patients with myocardial infarction and 
three with auricular fibrillation recovered without in- 
cident. 
There were two perioperative deaths in the endo- 
luminal repair group (4.7%). One patient died from 
renal failure and septicaemia following conversion to 
open repair for obstruction to the renal orifices by the 
endograft. The second had ventricular tachycardia and 
Table 3. Comparison of aneurysm rupture, systemic remote com- 
plications and deaths in both groups. 
Endoluminal No 
repair treatment 
0 1 Aneurysm rupture 
Systemic remote complications 
Renal insufficiency 
obstructive 
pre-renal 
post-renal 
contrast media induced 
Cardiac 
myocardial infarction 
cardiac arrhythmia 
TIA 
Deaths 
Perioperative 
Late 
Total 
2 2 
4 
1 
2 0 
1 2 
3 2 
a cardiac arrest 12 days after endoluminal repair. This 
patient had required balloon dilatation and stenting 
of the contralateral common iliac which occluded intra- 
operatively. He also required a femoral artery bypass 
for acute ischaemia of the contralateral limb within 
24 h of AAA repair. 
In follow-up of the endoluminal repair group, all 
grafts remained functional with no incidence of throm- 
bosis (other than one limb of a bifurcated graft), em- 
bolism or infection. The mean maximum diameter of 
AAA sac after successful endoluminal repair showed 
a progressive decrease from 4.41 cm to 3.92 cm at 12 
months. There was one late death from spontaneous 
rupture of the oesophagus 8 months after successful 
endoluminal AAA repair. 
No treatment group 
Sixty-seven patients with AAA 5 cm or less in diameter 
were managed conservatively with correction of risk 
factors. The mean maximum diameter of the AAA in 
this group at presentation was 4.08 cm. The growth 
rate of the AAA was an increase in mean maximum 
diameter of 0.52 cm per year. During the 4 year study 
period, 21 (31%) of the 67 AAA enlarged beyond 5 cm 
in maximum diameter. Eleven of the 21 patients whose 
AAA exceeded 5 cm in diameter were operated upon. 
Seven were repaired using the endoluminal method 
and four by the conventional open method. 
There was one death from aneurysm rupture in 
the no treatment group (1.5%). There was one non- 
aneurysm related death from myocardial infarction. 
Morbidity was limited to two non-fatal episodes of 
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myocardial infarction and one transient ischaemic 
attack. 
Discussion 
In assessing the relative merits of two methods of 
treatment, a concurrent comparison has a useful place. 
It provides an approximate estimate of the risks and 
benefits of each method. Such an estimate allows a 
decision to be made on whether a randomised trial of 
two methods is justified. While the randomised trial 
remains the "gold standard" for comparing two 
methods of treatment, there are disadvantages of using 
this method from the outset. On the one extreme, 
one method may be so obviously superior that those 
patients randomised tothe other method will be clearly 
disadvantaged and the trial may have to be suspended. 
On the other extreme, one method may be so haz- 
ardous as to render the randomisation of patients 
unethical. In this study the mortality in the group of 
patients with small AAA treated by endoluminal re- 
pair (n = 3) was similar to the group managed by no 
treatment (n =2). Endoluminal repair, however, had 
an unacceptably high rate of failure and conversion 
to open repair (14%) and a 25% vascular complication 
rate. These results suggest hat a randomised trial 
of endoluminal repair vs. no treatment will become 
justified in the subset of patients with small AAA 5 cm 
or less in diameter, when the mortality of endoluminal 
repair can be reduced and the incidence of com- 
plications can be reduced by further improvements in 
endoluminal technology. 
It is possible that the results of this study may 
have been skewed by an initial high mortality and 
complication rate associated with learning the endo- 
luminal method during the early phase. In fact, both 
perioperative deaths and four of six conversions to 
open repair occurred during the early phase of our 
experience with endoluminal graft techniques, up to 
the end of 1994. During 1995 and 1996, only two 
patients required conversion to open repair. Fur- 
thermore, five of the six conversions to open repair 
occurred in cases where a new device was being 
trialled for the first or second time only (and four of 
the six occurred with devices that are now superseded). 
Poor quality imaging equipment may also play a role; 
five of six conversions toopen repair occurred uring a 
period when we were using an older image intensifier, 
whereas only one has occurred since "state-of-the-art" 
imaging equipment was installed. 
It is also our experience that procedural com- 
plications are related to access sheath size. Until re- 
cently, all of our endoluminal cases were done via 
sheaths of 24F internal diameter (ID)/29F external 
diameter (ED) size. Recent devices may be introduced 
via sheaths of 18F ID/21F ED, and these newer access 
sheaths are more flexible. This is likely to reduce 
the incidence of vascular complications and improve 
outcome. Availability of smaller sheaths will also in- 
crease the proportion of patients who are candidates 
for endoluminal repair. 
These factors suggest that morbidity and mortality 
are related strongly to experience, technique and to 
specific device design. 
One of the premises on which this study was based 
was the nexus between small AAA and the presence 
of a proximal neck of sufficient length to enable en- 
doluminal repair to be undertaken. It is therefore of 
interest hat an AAA diameter of 5 cm or less is no 
guarantee ofsuitability for endoluminal repair. Indeed 
Armon and his colleagues 13 found little correlation 
between AAA diameter and suitability of the proximal 
neck for endoluminal repair. They found 19 of 44 
patients (43%) of AAA of diameter 4.5-5.4 cm to be 
unsuitable. They also found that shortening and 
widening of the proximal neck increases with an- 
eurysm size but only after the aneurysm expands 
beyond 7 cm in diameter. It is also of interest to note 
that in the present study only 26 of 43 (60%) of AAA 
were suitable for tube graft repair despite their small 
size. 
It must be acknowledged that a limitation in this 
study is the inability to conclude whether the risk of 
complication is greater with one or other device due 
to the small number of patients in which some of the 
devices were used. Analysis, however, did not reveal 
any difference in complication rate between the largest 
group of 27 patients with the White-Yu prosthesis and 
the remaining roup of 16 patients in which various 
prostheses were used. The evolution of these devices 
also makes it impossible to form definite conclusions 
regarding the role of endoluminal repair for small 
aneurysms at this time. In the present study the en- 
doluminal repair group have gained an asset in having 
their aneurysms repaired at a cost of early morbidity 
following operation. Itwould seem, however, that any 
proposal to screen for aneurysms with a view to 
treating them while they are small enough to be suit- 
able for endoluminal repair is premature since (i) 
the long-term outcome of endoluminal repair is not 
known; (ii) the current morbidity of this method is 
high even with small aneurysms; and (iii) a significant 
number of small aneurysms will be unsuitable ~espite 
their size. Improvements in results and devices during 
1995 and 1996 suggest that there will be a role for a 
prospective randomised study in the future. 
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